Asthma is a lung condition that can make your airways swell, narrow, and fill with mucus. "This causes recurrent episodes of coughing, wheezing, and chest tightness," says Dr. Laura Conrad, director ...

In children with moderate-to-severe asthma, telemedicine intervention with therapy in schools improves asthma outcomes, reducing symptoms and healthcare use, a recent study shows.

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

A new injectable medicine is giving hope to people with asthma by helping them breathe better. The drug, called dupilumab ...

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with ...

The roughly 28 million Americans living with asthma are familiar with the challenges of inflammation and narrowing of the airways that affects how the lungs are supplied with air. That’s not including ...

In the WAYFINDER trial, tezepelumab reduced oral corticosteroid use in patients with severe asthma, with well-controlled ...

Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved asthma control.

Patients with asthma and T2 diabetes using SGLT2 inhibitors have a significantly decreased mortality risk within 30 days of an asthma exacerbation.

Patients with chronic rhinosinusitis with nasal polyps and uncontrolled asthma experienced greater improvements in lung ...

Women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime, according to a study published today (Monday) in ERJ Open Research [1].

Mepolizumab significantly reduced healthcare resource utilization, including hospitalizations and emergency department visits, in patients with severe eosinophilic asthma over two years. The treatment ...